Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucinactant BAL for Meconium Aspiration Syndrome
NCT00004500Phase 3Terminated
- Sponsor
- Windtree Therapeutics, Inc.
- Start
- Mar 2000
- Primary completion
- Nov 2002
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of lucinactant in Meconium aspiration syndrome (MAS), sponsored by Windtree Therapeutics, Inc.. Started Mar 2000; status: terminated.
02
Drugs
lucinactant
03
Conditions
Meconium aspiration syndrome (MAS)
Beyond the preview
Go deeper on NCT00004500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004500.